𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1024 IDENTIFICATION OF SERUM PROTEOGLYCANS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS

✍ Scribed by Nault, J.C.; Guyot, E.; Laguillier, C.; Chevret, S.; Ganne-Carrie, N.; N'Kontchou, G.; Beaugrand, M.; Seror, O.; Trinchet, J.-C.; Lasalle, P.; Charnaux, N.; Delhedde, M.; Sutton, A.; Nahon, P.


Book ID
123364079
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
67 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Diagnostic and prognostic role of serum
✍ Hasan Γ–zkan; Harun Erdal; Erdem KoΓ§ak; HΓΌseyin Tutkak; Zihni Karaeren; Mustafa Y πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

Ξ±-Feto protein (AFP) is the widely used tumor marker in the diagnosis of hepatocellular carcinoma (HCC). The aim of this study was to assess the diagnostic and prognostic validity of a novel marker, serum Glypican-3 (GPC3) and to compare AFP in patients with HCC. One hundred and twenty-eight patient